---
title: "Humacyte’s ATEV granted US FDA Regenerative Medicine Advanced Therapy designation for advanced PAD"
date: "2024-07-08T11:13:17.000Z"
publishedDate: "8 juillet 2024"
summary: "Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This RMAT designation was granted at the same time as the FDA cleared a new Investigational [&#8230;] The post Humacyte&#8217;s ATEV granted US FDA Regenerative Medicine Advanced Therapy designation for advanced PAD appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/humacytes-atev-granted-us-fda-regenerative-medicine-advanced-therapy-designation-for-advanced-pad/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-07-08-humacytes-atev-granted-us-fda-regenerative-medicine-advanced-therapy-designation-for-advanced-pad"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/humacytes-atev-granted-us-fda-regenerative-medicine-advanced-therapy-designation-for-advanced-pad/"
---

![Humacyte’s ATEV granted US FDA Regenerative Medicine Advanced Therapy designation for advanced PAD](https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/humacytes-atev-granted-us-fda-regenerative-medicine-advanced-therapy-designation-for-advanced-pad/*

## L’essentiel

Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This RMAT designation was granted at the same time as the FDA cleared a new Investigational [&#8230;] The post Humacyte&#8217;s ATEV granted US FDA Regenerative Medicine Advanced Therapy designation for advanced PAD appeared first on Vascular News .

## Lien source

https://vascularnews.com/humacytes-atev-granted-us-fda-regenerative-medicine-advanced-therapy-designation-for-advanced-pad/
